Drug Standards of China 2025;26(1):23-27
doi:10.19778/j.chp.2025.01.004
Introduction of the main addition and revision of the Chinese Pharmacopoeia 2025 Edition(Volume Ⅱ)
Yi ZHOU 1 ; Zhijun WANG 1 ; Zhihua YUE 1 ; Qilei CHENG 1 ; Ruiqi YUE 1 ; Xi YANG 1 ; Wei GUO 1 ; Shuangcheng MA 1
Affiliations
Keywords
The Chinese Pharmacopoeia 2025 Edition(Volume Ⅱ)(ChP 2025,Volume Ⅱ); the addition and revision of drug monographs; drug standard
Country
China
Language
Chinese
Abstract
The Pharmacopeia of the People's Republic of China 2025 Edition(referred to as the Chinese Pharmaco-poeia 2025 Edition,ChP 2025)will be promulgated and implemented.This article introduces the process of devel-opment of ChP 2025 Edition(Volume Ⅱ),including the selection,the revision of general notices,the addition and revision of drug monographs,etc.,and provides some analysis and examples to illustrate,which can facilitate the readers to understand and implement the ChP 2025 Edition(Volume Ⅱ).
备案号: 11010502037788, 京ICP备10218182号-8)